THE USE OF DENSITOMETRY IN ASSESSING THE RISK OF FRACTURES AND LONG-TERM PROGNOSIS IN PATIENTS RECEIVING HEMODIALYSIS TREATMENT

Chronic kidney disease (CKD) in the terminal stage leads to severe metabolic damage to 22 bones, which is often complicated by osteoporosis and fractures. The possibilities of dual-energy X-ray absorptiometry in assessing the risk of fractures in patients with CKD are still being questioned, and the possibilities of this research method in assessing the prognosis of patients receiving hemodialysis treatment remain poorly understood